Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Heart Failure
Clinical trial register · Poland

Heart Failure Trials in Poland, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2709 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2709
Studies in scope
all four open statuses
1380
Recruiting now
open to new participants
510
Lead sponsors
across recruiting studies
Top sites
Warsaw 17 Krakow 12 Wroclaw 11 Bialystok 7 Lodz 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novo Nordisk A/S4 Boehringer Ingelheim2 Medical University of Warsaw2 Insel Gruppe AG, University Hospital Bern2 Jagiellonian University2 Alleviant Medical, Inc.2 Colorado Prevention Center2 Echosens1 Bristol-Myers Squibb1 University in Zielona Góra1 Pfizer1 Cytokinetics1 InnovHeart1 Universitat Internacional de Catalunya1 Viscofan1 National Institute of Cardiology, Warsaw, Poland1 4th Military Clinical Hospital with Polyclinic, Poland1 Ancora Heart, Inc.1 Wroclaw Medical University1 John Paul II Hospital, Krakow1 Merck Sharp & Dohme LLC1 Universitaire Ziekenhuizen KU Leuven1 V-Wave Ltd1 Medical University of Lodz1 Cardiac Dimensions, Inc.1 Show all 31
Site location
Warsaw17 Krakow12 Wroclaw11 Bialystok7 Lodz7 Poznan7 Lublin6 Katowice5 Bydgoszcz5 Zabrze5 Gdynia4 Bielsko-Biala3 Opole3 Gdansk3 Oświęcim3 Szczecin2 Przemyśl2 Puławy2 Biała Podlaska2 Chojnice2 Częstochowa2 Chrzanów2 Tychy2 Lódz1 Nowa Sól1 Show all 43
All 43 locations
Target enrolment
to

Heart Failure trials in Poland

40 of 2709 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Not yet open
Zoll Medical Corporation
Not applicable
800
Warsaw
2026-10-01
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Leszno, Chrzanów, Tarnów, Lublin, Płock, Gdynia, Ustroń, Szczecin
2026-05-11
Recruiting
Echosens
Not applicable
149
Wroclaw
2026-04-23
Not yet open
Universitat Internacional de Catalunya
Observational
90
Wroclaw
2026-03
Active, closed
Jagiellonian University
Observational
700
Krakow
2026-01-29
Recruiting
Pacing Advancements With Cost and Experience VALuation for Unified Patient-Led Clinical Evidence - the PACEVALUE Study
NCT07276139Cardiomyopathy, Secondary, Arrhythmias, Cardiac, Heart Failure, Pacing Induced Cardiomyopathy
Insel Gruppe AG, University Hospital Bern
Observational
4,500
Rzeszów, Warsaw, Wroclaw, Zabrze
2026-01-01
Not yet open
Viscofan
Phase 1
10
Katowice - Ochojec
2025-09-01
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Biała Podlaska, Bielsko-Biala, Krakow, Przemyśl, Warsaw
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Wroclaw, Lublin, Bialystok, Szczecin, Bielsko-Biala, Krakow, Lodz, Przemyśl
2025-06-27
Recruiting
Pfizer
Phase 2
620
Poznan, Bydgoszcz, Torun, Puławy, Sopot, Katowice
2025-06-19
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bielsko-Biala, Bydgoszcz, Gdynia, Krakow, Legnica, Lodz, Lublin, Piaseczno
2025-05-20
Recruiting
AstraZeneca
Phase 3
11,300
Bialystok, Biała Podlaska, Bydgoszcz, Chojnice, Chrzanów, Częstochowa, Gdansk, Gdynia
2025-03-14
Recruiting
Alleviant ALLAY-HFrEF Study
NCT06812533Heart Failure
Alleviant Medical, Inc.
Not applicable
350
Opole, Warsaw, Wroclaw
2025-03-10
Active, closed
Wroclaw Medical University
Phase 4
200
Wroclaw
2024-12-31
Recruiting
Cytokinetics
Phase 3
1,800
Warsaw, Bialystok, Krakow, Lodz, Miechów, Opole, Poznan, Ruda Śląska
2024-12-19
Recruiting
University Hospital, Geneva
Not applicable
220
Krakow
2024-10-01
Recruiting
Colorado Prevention Center
Phase 3
2,600
Lublin, Oświęcim, Krakow, Lodz, Tychy
2024-08-20
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bialystok, Bydgoszcz, Chojnice, Częstochowa, Elblag, Gdansk, Gdynia, Katowice
2024-06-17
Recruiting
4th Military Clinical Hospital with Polyclinic, Poland
Phase 3
188
Wroclaw, Warsaw
2024-04-15
Recruiting
InnovHeart
Not applicable
30
Katowice, Warsaw
2024-04-04
Active, closed
Novo Nordisk A/S
Phase 3
673
Bydgoszcz, Włocławek, Krakow, Oświęcim, Jelenia Góra, Wroclaw, Puławy, Żyrardów
2024-04-01
Recruiting
The STOP-MED CTRCD Trial
NCT06183437Heart Failure, Cardiotoxicity, Cardiac Toxicity, Antineoplastics Toxicity
Dinesh Thavendiranathan
Phase 4
335
Warsaw
2024-03-04
Recruiting
Colorado Prevention Center
Phase 3
5,200
Katowice, Krakow, Lodz, Lublin, Oświęcim, Tychy
2024-01-17
Recruiting
Multimodal Cardiac Imaging Registry in Patients with Atrial Fibrillation
NCT06584266Atrial Fibrillation and Flutter, Heart Failure, Artificial Intelligence (AI), Echocardiography
University in Zielona Góra
Observational
3,000
Nowa Sól, Katowice, Krakow, Warsaw, Zielona Góra
2024-01-01
Recruiting
ChAracterization of Patients and Treatment OUtcomes in Severe Tricuspid Regurgitation
NCT06838611Tricuspid Regurgitation, Heart Failure, Valve Heart Disease
Medical University of Warsaw
Observational
300
Warsaw
2023-11-14
Active, closed
Bristol-Myers Squibb
Phase 2
227
Lódz, Bialystok
2023-11-07
Recruiting
Merck Sharp & Dohme LLC
Phase 2/3
342
Gdansk
2023-05-31
Active, closed
Telemonitoring of HFrEF Patients
NCT07835490Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Medical University of Lodz
Not applicable
60
Lodz
2023-02-21
Recruiting
Lesser Poland Cracovian Heart Failure Registry
NCT05746923Heart Failure, Heart Failure Acute
Jagiellonian University
Observational
2,500
Krakow
2023-02-15
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Opole, Poznan, Wejherowo, Wroclaw, Zabrze
2023-01-10
Active, closed
Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.
NCT04654988Myocarditis, Heart Failure, Endomyocardial Biopsy, Cardiomyopathies, Secondary
DrugsAzathioprine·Prednisone
Medical University of Warsaw
Phase 4
100
Warsaw
2022-12-01
Active, closed
Empagliflozin in Hypertrophic Cardiomyopathy
NCT05182658Hypertrophic Cardiomyopathy, Heart Failure
DrugDapagliflozin
National Institute of Cardiology, Warsaw, Poland
Phase 3
250
Bialystok, Warsaw
2022-06-01
Recruiting
TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure
NCT05250349Heart Failure, Cognitive Impairment, Carotid Stenosis
John Paul II Hospital, Krakow
Observational
300
Krakow
2021-09-01
Active, closed
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
NCT04225520Left Ventricular Dyssynchrony, Heart Failure, Cardiomyopathy, Dilated, Cardiac Remodeling, Ventricular
Universitaire Ziekenhuizen KU Leuven
Not applicable
500
Poznan, Warsaw, Zabrze
2020-12-10
Active, closed
Ancora Heart, Inc.
Not applicable
132
Warsaw
2019-01-15
Active, closed
V-Wave Ltd
Not applicable
605
Warsaw, Wroclaw
2018-09-19
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Lodz, Poznan, Warsaw
2018-05-14
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Poznan
2018-01-01
Recruiting
Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation
NCT07852221Atrial Fibrillation (AF), Cardiomyopathy, Secondary, Pacing-Induced Cardiomyopathy, Heart Failure
Insel Gruppe AG, University Hospital Bern
Observational
2,600
Zabrze
2011-01-05
Recruiting
Medtronic
Observational
20,000
Poznan, Warsaw, Zabrze
1983-01
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 November 2026. https://priyalifescience.com/clinical-trials-poland/condition/heart-failure

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,709 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies listing the condition Heart Failure.

How many Heart Failure trials are recruiting in Poland?

26 of the 40 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Heart Failure), 40 studies
PhaseStudiesRecruitingShare
Not applicable11627.5%
Observational10725%
Phase 310825%
Phase 24310%
Phase 4317.5%
Phase 1102.5%
Phase 2/3112.5%

Most active sponsors

Lead sponsors with the most studies (Heart Failure)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S43
Alleviant Medical, Inc.22
Boehringer Ingelheim22
Colorado Prevention Center22
Insel Gruppe AG, University Hospital Bern22
Jagiellonian University21
Medical University of Warsaw21
4th Military Clinical Hospital with Polyclinic, Poland11
Ancora Heart, Inc.10
AstraZeneca11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.